Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Announces Appointment of New Chief Financial Officer | BioSpace
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Beats Analysts on Second Quarter Operating Income, Revenues | Ctech
Teva | Partnership | Direct Relief
Efi Benmeir - SVP Finance & CFO International Markets - Teva Pharmaceutical Industries Ltd. | LinkedIn
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals Industries Ltd. to buy Rimsa for $2.3 billion - Pittsburgh Business Times
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Teva Reports Third Quarter 2022 Financial Results
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceutical S&P rating outlook changed to stable | Seeking Alpha
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
